An Open Label Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-75
SponsorPepsiCo Global R&D

About this trial

The purpose of this study is to:

1. Understand the participant experience using a health and wellness product and effects of the study product on GLP-1 users and those trying to lose weight 2. Understand how participants may use and accept a health and wellness product 3. Understand the side effects of a health and wellness product 4. Evaluate the quality and effects of a health and wellness product on participant health through self-reported measures (electronic surveys) and biomarker collections.

Eligibility criteria

Qualifiers

Adults, at least 21-75 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities.

Assigned sex at birth will determine sex-specific recruitment and surveys (male vs female) employed, when needed

Resides in the United States

Has the opportunity for at least 30% improvement in their primary health outcome

Disqualifiers

Report being pregnant, trying to become pregnant, or breastfeeding

Unable to provide a valid US shipping address and mobile phone number

Reports current enrollment in another clinical trial

Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)

Trial design

Treatments tested in this trial

  • A ready-to-mix beverage containing protein, fiber, and electrolytes

Treatment groups

133 Participants
are divided into 1 treatment group

Sponsors and collaborators

PepsiCo Global R&D

Lead sponsor

Radicle Science Inc.

Collaborator